FCUV
FCUVCIK 0001590418
Micro
Revenue $255K
Assets $20M
as of Oct 11, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (MRSH 10-Q) is open in full — no account needed.
8-K
Filed Sep 8, 2026
· Period ending Sep 5, 2026
Summary not yet generated.
8-K
Filed Aug 19, 2026
· Period ending Aug 18, 2026
Summary not yet generated.
Partner
Trade FCUV commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
10-Q
Filed Aug 14, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
8-K
Filed Jun 25, 2026
· Period ending Jun 19, 2026
Summary not yet generated.
8-K
Filed Jun 18, 2026
· Period ending Jun 18, 2026
Summary not yet generated.
8-K
Filed May 26, 2026
· Period ending May 15, 2026
Summary not yet generated.
S-1/A
Filed May 1, 2026
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 14, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | ||||
| Rental revenue | 651,950 | – | 651,950 | – |
| Other revenue | 23,220 | 35,330 | 71,193 | 225,585 |
| Total Revenue | 675,170 | 35,330 | 723,143 | 225,585 |
| Cost and Operating Expenses | ||||
| Property operating expenses | 259,663 | – | 259,663 | – |
| Cost of other revenue | 17,227 | 47,742 | 49,956 | 207,453 |
| Depreciation and amortization | 201,024 | 5,506 | 207,746 | 10,959 |
| Selling expense | 691 | 7,420 | 33,539 | 56,400 |
| Compensation officers and directors | 117,638 | 125,357 | 235,189 | 250,744 |
| Research and development | 362,165 | 467,297 | 626,962 | 839,555 |
| Professional fees | 751,144 | 429,155 | 1,136,349 | 902,146 |
| General and administrative | 515,193 | 495,613 | 995,025 | 772,615 |
| Total Cost and Operating Expenses | 2,224,745 | 1,578,090 | 3,544,429 | 3,039,872 |
| Loss from Operations | (1,549,575) | (1,542,760) | (2,821,286) | (2,814,287) |
| Other Income (Expense): | ||||
| Interest income (expense), net | (86,002) | 12,130 | (45,912) | 34,018 |
| Unrealized gain on marketable equity securities | 14,013 | 17,745 | – | 14,753 |
| Realized gain on marketable equity securities | 98,936 | – | 98,936 | – |
| Other income, net | 3,670 | 7,237 | 3,226 | 8,490 |
| Total other income | 30,617 | 37,112 | 56,250 | 57,261 |
| Net Loss | (1,518,958) | (1,505,648) | (2,765,036) | (2,757,026) |
| Accretion of redeemable preferred stock | – | – | (226,666) | – |
| Net loss to common stockholders’ | (1,518,958) | (1,505,648) | (2,991,702) | (2,757,026) |
| Other comprehensive items | ||||
| Foreign currency translation loss | 6,133 | (4,065) | 11,159 | (10,433) |
| Total comprehensive loss | (1,512,825) | (1,509,713) | (2,980,543) | (2,767,459) |
| Basic net income loss per share: | ||||
| Basic net loss per share | (2.69) | (7.99) | (7.31) | (15.34) |
| Weighted Average Number of Common Shares Outstanding: Basic and Fully Diluted | 564,651 | 188,405 | 409,315 | 179,775 |
Condensed Consolidated Balance Sheets
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current Assets: | ||
| Cash | 1,600,258 | 7,934,958 |
| Accounts receivable, net | 68,643 | 7,125 |
| Inventories, net | 84,950 | 99,813 |
| Other receivables | – | 20,000 |
| Prepaid expenses | 243,482 | 492,953 |
| Marketable securities | – | 22,887 |
| Deposit current portion | 46,655 | 69,393 |
| Total Current Assets | 2,043,988 | 8,647,129 |
| Property and equipment, net | 17,575,589 | 66,705 |
| Operating lease right-of-use asset | 149,172 | 12,501 |
| Capitalized software costs | 247,865 | 159,179 |
| Deposits | 14,446 | – |
| Total Assets | 20,031,060 | 8,885,514 |
| LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY | ||
| Current Liabilities: | ||
| Accounts payable and accrued liabilities | 417,089 | 358,007 |
| Other current liabilities | 234,191 | – |
| Loan, current portion | 129,290 | – |
| Lease liability, current portion | 55,853 | 8,464 |
| Total Current Liabilities | 836,423 | 366,471 |
| Non-Current Liabilities: | ||
| Loan, less current portion | 10,869,416 | – |
| Other liability | 63,484 | – |
| Lease liability, less current portion | 61,701 | – |
| Total Liabilities | 11,831,024 | 366,471 |
| Redeemable Preferred Stock: | ||
| Series B convertible redeemable preferred stock, par value $0.001 per share, 15,000 shares authorized; 0 and 7,263 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | – | 5,946,284 |
| Contingencies | ||
| Stockholders’ Equity: | ||
| Common stock, par value $0.001 per share, 1,000,000,000 shares authorized; 702,745 and 228,774 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 703 | 229 |
| Treasury stock (54,494 and 4,271 shares held at June 30, 2026 and December 31, 2025, respectively) | (848,533) | (494,390) |
| Additional paid-in capital | 43,071,198 | 34,038,844 |
| Shares to be issued, common shares (1,534 and 1,449 shares at June 30, 2026 and December 31, 2025, respectively) | 12,019 | 82,884 |
| Accumulated deficit | (34,015,113) | (31,023,411) |
| Accumulated other comprehensive loss | (20,238) | (31,397) |
| Total Stockholders’ Equity | 8,200,036 | 2,572,759 |
| Total Liabilities, Redeemable Preferred Stock and Stockholders’ Equity | 20,031,060 | 8,885,514 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net Loss | (2,765,036) | (2,757,026) |
| Adjustments to reconcile net loss to net cash from operating activities: | ||
| Inventory reserve | – | 1,644 |
| Depreciation expense | 198,588 | 10,959 |
| Amortization expense | 9,158 | – |
| Unrealized gain on marketable equity securities | – | (14,753) |
| Realized gain on marketable equity securities | (98,936) | – |
| Stock-based compensation shares | 199,022 | 189,861 |
| Stock based compensation options | 4,504 | 20,568 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (61,518) | 5,434 |
| Inventories | 14,863 | (13,943) |
| Other receivable | 20,000 | (88,201) |
| Prepaid expenses | 251,799 | 4,186 |
| Deposit | 8,688 | 2,593 |
| Operating lease right-of-use asset | 40,435 | 47,360 |
| Accounts payable and accrued liabilities | 59,082 | 91,354 |
| Other current liabilities | 297,675 | (64,638) |
| Lease liabilities | (67,601) | (83,686) |
| Net cash flows used in operating activities | (1,889,277) | (2,648,288) |
| Cash flows from investing activities: | ||
| Purchase of property and equipment | (6,656,031) | (25,091) |
| Capitalized software costs | (97,844) | – |
| Proceeds from sale of marketable securities | 121,823 | – |
| Net cash flows used in investing activities | (6,632,052) | (25,091) |
| Cash flows from financing activities: | ||
| Redemption of preferred stock | (961,861) | – |
| Repayment on bank loan | (51,294) | – |
| Shares issued for pre-funded units | 3,547,348 | – |
| Stock issued for private placement | – | 381,224 |
| Purchases of treasury stock | (354,143) | (173,837) |
| Net cash flows provided by financing activities | 2,180,050 | 207,387 |
| Effect of exchange rate | 6,579 | (12,125) |
| Net change in cash | (6,334,700) | (2,478,117) |
| Cash beginning of period | 7,934,958 | 3,589,318 |
| Cash end of period | 1,600,258 | 1,111,201 |
| Supplemental cash flow disclosure: | ||
| Cash paid for income taxes | – | 3,525 |
| Cash paid for interest | 86,103 | – |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Accretion of redeemable series B preferred stock discount | 226,666 | – |
| Conversion of series B preferred stock to common stock | 5,127,200 | – |
| Gain on cancellation of preferred stock | 83,890 | – |
| Right-of-use assets obtained in exchange for operating lease liabilities | 175,271 | – |
| Issuance to bank loan on building acquisition | 11,050,000 | – |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗